Overview
Support Groups
Latest News
Events
Clinical Trials
Alport syndrome
-
Jan 30, 2019 finheadlines.com
Comparison of Akebia Therapeutics Inc. (AKBA) and Regulus Therapeutics Inc. (NASDAQ:RGLS) – The FinHeadLines
Read More -
Jan 30, 2019 endigest.com
Reviewing Cyclacel Pharmaceuticals Inc. (CYCC)’s and Regulus Therapeutics Inc. (NASDAQ:RGLS)’s results – EN Digest
Read More -
Jan 30, 2019 hinewulm.com
Comparison of Regulus Therapeutics Inc. (RGLS) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) – The Hi New Ulm
Read More -
Jan 27, 2019 www.fairfieldcurrent.com
Head-To-Head Survey: Akcea Therapeutics (NASDAQ:AKCA) and Reata Pharmaceuticals (RETA) – Fairfield Current
Read More -
Jan 22, 2019 www.thejc.com
Wife gives husband her kidney in life-saving double operation – Jewish Chronicle
Read More -
Jan 21, 2019 alportsyndromenews.com
Co-occurrence of aHUS, TMA, and Alport Syndrome Suggest Shared Mechanism, Case Report Says – Alport Syndrome News
Read More -
Jan 20, 2019 www.fairfieldcurrent.com
Regulus Therapeutics Inc (RGLS) Director Stelios Papadopoulos Acquires 50000 Shares – Fairfield Current
Read More -
Jan 14, 2019 alportsyndromenews.com
In XLAS, COL4A5 Mutations Determine Progression of Hearing Loss, Study Finds – Alport Syndrome News
Read More -
Jan 10, 2019 www.nasdaq.com
Top 5 Losers In Healthcare Sector (PAVM, ATOS, TBIO…) – Nasdaq
Read More
